Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 136

Sort by

Sort Order Select

Journal Articles

The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism

Michael Heider, Ruth Eichner, Jacob Stroh, Anna Kuisl, Jana Zecha, Jannis Lawatscheck, Martina Rudelius, Anne-Kathrin Garz, Simone Lemeer, Christian Peschel, Ulrich Keller, MD, Katharina Götze, Johannes Buchner, Bernhard Kuster, Vanesa Fernandez-Saiz, Florian Bassermann, MD PhD

Blood (2019) 134 (Supplement_1): 314.

https://doi.org/10.1182/blood-2019-129064

Published: 2019

Journal Articles

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

Blood (2019) 134 (Supplement_1): 3741.

https://doi.org/10.1182/blood-2019-125973

Published: 2019

Journal Articles

MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study

Marc S Raab, MD PhD, Manik Chatterjee, MD, Hartmut Goldschmidt, MD, Hermine Agis, MD, Igor Blau, MD PhD, Hermann Einsele, MD, Monika Engelhardt, MD, Barbara Ferstl, MD, Martin Gramatzki, MD, Christoph Rollig, MD MSC, Katja Weisel, MD, Tiantom Jarutat, MD, Dominika Weinelt, MD, Mark Winderlich, PhD, Christian Peschel, MD

Blood (2018) 132 (Supplement 1): 153.

https://doi.org/10.1182/blood-2018-153

Published: 2018

Journal Articles

Azacitidine Directly Acts on the Mesenchymal Stromal Cell Compartment in Myelodysplastic Syndromes to Alter Niche Function and Suppress Malignant Hematopoeitic Stem/Progenitor Cells

Catharina Wenk, MD, Anne-Kathrin Garz, MSc, Christina Huberle, MD, Sonja Grath, PhD, Denis Witham, Marie Weickert, Msc, Julia Niggemeyer, Msc, Judith Hecker, MD, Michele Kyncl, MSc, Catharina Müller-Thomas, MD, Christopher Mulholland, MSc, Robert A.J. Oostendorp, PhD, Klaus H. Metzeler, MD, Christian Peschel, MD, Katharina S Götze, MD

Blood (2017) 130 (Supplement 1): 1683.

https://doi.org/10.1182/blood.V130.Suppl_1.1683.1683

Published: 2017

Journal Articles

Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity

Simon Heidegger, MD, Alexander Wintges, Sarah Bek, Martina Schmickl, Jürgen Ruland, MD, Marcel R.M. van den Brink, MD PhD, Christian Peschel, MD, Tobias Haas, MD, Hendrik Poeck, MD

Blood (2017) 130 (Supplement 1): 693.

https://doi.org/10.1182/blood.V130.Suppl_1.693.693

Published: 2017

Journal Articles

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

Stefanie Jilg, MD, Johanna Kauschinger, MDcal student, Veronika Reidel, MDcal student, Catharina Müller-Thomas, MD, Richard Hauch, MDcal student, Johannes Schauwecker, MD, Burkhard Schmidt, MD, Ulrike Höckendorf, Dipl. Humanbiol., Christian Peschel, MD, Katharina Götze, MD, Philipp J. Jost, MD

Blood (2016) 128 (22): 4297.

https://doi.org/10.1182/blood.V128.22.4297.4297

Published: 2016

Journal Articles

Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients

Stefan Habringer, MD, Peter Herhaus, Margret Schottelius, PhD, Constantin Lapa, MD, Rouzanna Istvanffy, PhD, Katharina Götze, Katja Steiger, DVM, Binje Vick, PhD, Christian Peschel, MD, Robert Oostendorp, PhD, Irmela Jeremias, MD, Hans-Jürgen Wester, PhD, Goetz Ulrich Grigoleit, MD, Ulrich Keller, MD

Blood (2016) 128 (22): 4055.

https://doi.org/10.1182/blood.V128.22.4055.4055

Published: 2016

Journal Articles

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Blood (2016) 128 (22): 993.

https://doi.org/10.1182/blood.V128.22.993.993

Published: 2016

Journal Articles

Evasion of Necroptosis and Inflammasome Activation Promotes Myeloid Leukemogenesis

Ulrike Höckendorf, Dipl. Humanbiol., Yabal Monica, PhD, Christian Peschel, MD, Philipp J. Jost, MD

Blood (2016) 128 (22): 2856.

https://doi.org/10.1182/blood.V128.22.2856.2856

Published: 2016

Journal Articles

A Phase I/IIa Study of the CD38 Antibody MOR202 Alone and in Combination with Pomalidomide or Lenalidomide in Patients with Relapsed or Refractory Multiple Myeloma

Marc S. Raab, MD, Manik Chatterjee, MD, Hartmut Goldschmidt, MD, Hermine Agis, MD, Igor Blau, Hermann Einsele, MD, Monika Engelhardt, MD PhD, Barbara Ferstl, MD, Martin Gramatzki, MD, Christoph Röllig, MD, Katja Weisel, MD, Tiantom Jarutat, MD, Dominika Weinelt, MD, Jan Endell, PhD, Rainer Boxhammer, PhD, Christian Peschel, MD

Blood (2016) 128 (22): 1152.

https://doi.org/10.1182/blood.V128.22.1152.1152

Published: 2016

Journal Articles

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Ajib Salem, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Penter Livius, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, MD, Michael Lübbert, MD, Ralph Wäsch, MD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Omid Shah, MD, Robert S. Negrin, MD, Mats Brune, MD PhD, Alexandros Spyridonidis, MD PhD, Annette Schmitt-Graeff, MD, Walter J.F.M. van der Velden, MD PhD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MD PhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Jakob R. Passweg, Joerg Halter, MD, Gérard Socié, MD PhD, Dietrich W. Beelen, Prof. Dr. MD, Christian Peschel, MD, Andreas Neubauer, Jürgen Finke, Justus Duyster, MD, Nikolas von Bubnoff, MD

Blood (2016) 128 (22): 4561.

https://doi.org/10.1182/blood.V128.22.4561.4561

Published: 2016

Journal Articles

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma- Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group ( GLSG )

Vindi Jurinovic, M.Sc., Bernd Metzner, MD, PhD, Michael Pfreundschuh, MD, PhD, Norbert Schmitz, MD, PhD, Hannes Wandt, MD, PhD, Christian Peschel, MD, PhD, Martin Dreyling, MD PhD, Wolfgang Hiddemann, MD, PhD, Eva Hoster, PhD, Michael Unterhalt, PhD, Oliver Weigert, MD

Blood (2016) 128 (22): 3464.

https://doi.org/10.1182/blood.V128.22.3464.3464

Published: 2016

Journal Articles

Integration of innate into adaptive immune responses in ZAP-70–positive chronic lymphocytic leukemia

Michaela Wagner, Madlen Oelsner, Andrew Moore, Frederik Götte, Peer-Hendrik Kuhn, Torsten Haferlach, Michael Fiegl, Christian Bogner, E. Joanna Baxter, Christian Peschel, George A. Follows, Ingo Ringshausen

Blood (2016) 127 (4): 436–448.

https://doi.org/10.1182/blood-2015-05-646935

Published: 2016

Includes: Supplemental data

Journal Articles

Identification of CXCR4 Expression By Targeted PET/MR Imaging in Patients with Acute Myeloid Leukemia (AML)

Peter Herhaus, Stefan Habringer, Kathrin Philipp-Abbrederis, Tibor Vag, Carlos Gerngroß, Alexander Höllein, Torben Altmann, Catharina Müller-Thomas, Julia Slotta-Huspenina, Christian Peschel, Markus Schwaiger, Hans-Jürgen Wester, Mareike Verbeek, Karsten Spiekermann, Katharina Götze, Ulrich Keller

Blood (2015) 126 (23): 1275.

https://doi.org/10.1182/blood.V126.23.1275.1275

Published: 2015

Journal Articles

NIPA As a Novel Regulator of Aging and Stress Response of the Primitive HSC Pool

Stefanie Kreutmair, Rouzanna Istvanffy, PhD, Cathrin Klingeberg, PhD, Christine Dierks, MD, Christian Peschel, MD, Robert A.J. Oostendorp, BSc, MSc, PhD, Justus Duyster, MD PhD, Anna Lena Illert, MD

Blood (2015) 126 (23): 1155.

https://doi.org/10.1182/blood.V126.23.1155.1155

Published: 2015

Journal Articles

Significance of the IL-3 Receptor Beta Chain (IL-3Rbc) for FLT3-ITD Dependent Oncogeneic Signaling in AML

Christoph Rummelt, Sivahari Prasad Gorantla, PhD, Philip Keye, Kathrin Klaesener, Venkatesh Rao, Christian Peschel, MD, Michael Reth, Prof., PhD, Justus Duyster, MD PhD, Nikolas von Bubnoff, Prof., PhD

Blood (2015) 126 (23): 3660.

https://doi.org/10.1182/blood.V126.23.3660.3660

Published: 2015

Journal Articles

Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group

Norbert Schmitz, MD PhD, Maike Nickelsen, MD, Marita Ziepert, PhD, Mathias Haenel, MD, Andreas Viardot, MD, Martin H. Dreyling, MD PhD, Peter Borchmann, MD, Carsten Bokemeyer, MD, Christian Peschel, MD, Hans-Heinrich Wolf, MD, Rolf Mahlberg, MD, Michael Pfreundschuh, MD, Bertram Glass, MD

Blood (2015) 126 (23): 474.

https://doi.org/10.1182/blood.V126.23.474.474

Published: 2015

Journal Articles

The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy

Simon Heidegger, MD, Diana Kreppel, Michael Bscheider, MD, Alexander Wintges, Sarah Bek, Martina Schmickl, Jürgen Ruland, MD, Christian Peschel, MD, Marcel van den Brink, MD, Tobias Haas, MD, Hendrik Poeck, MD

Blood (2015) 126 (23): 3436.

https://doi.org/10.1182/blood.V126.23.3436.3436

Published: 2015

Journal Articles

Azacitidine in Combination with the Selective FLT3 Kinase Inhibitor Crenolanib Effectively Disrupts Stromal Protection of CD34+ Leukemia-Initiating Cells (LIC) in FLT3-ITD+ Acute Myeloid Leukemia (AML)

Anne-Kathrin Garz, M.Sc., Stefan Habringer, Saskia Wolf, Binje Vick, PhD, Marie-Theresa Weickert, M.Sc., Irmela Jeremias, MD, Karsten Spiekermann, MD, Christian Peschel, MD, Robert A.J. Oostendorp, PhD, Ulrich Keller, Katharina S. Götze, MD

Blood (2015) 126 (23): 676.

https://doi.org/10.1182/blood.V126.23.676.676

Published: 2015

Journal Articles

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Robert Zeiser, MD, Andreas Burchert, MD, Claudia Lengerke, MD, Mareike Verbeek, Kristina Maas-Bauer, MD, Stephan Metzelder, MD, Silvia Spoerl, MD, Markus Ditschkowski, MD, Matyas Ecsedi, MD, Katja Sockel, MD, Francis Ayuk, MD, Salem Ajib, MD, Flore Sicre de Fontbrune, MD, Il-Kang Na, MD, Livius Penter, MD, Udo Holtick, MD PhD, Dominik Wolf, MD, Esther Schuler, MD, Everett Meyer, MD PhD, Petya Apostolova, MD, Hartmut Bertz, MD, Reinhard Marks, Michael Luebbert, MD, Ralph M. Waesch, MD PhD, Christof Scheid, MD PhD, Friedrich Stölzel, MD, Rainer Ordemann, MD, Gesine Bug, MD, Guido Kobbe, MD, Robert Negrin, MD, Mats L Brune, Alexandros Spyridonidis, Annette Schmitt-Graeff, MD, Walter van der Velden, MD, Gerwin Huls, MD PhD, Stephan Mielke, MD, Goetz Ulrich Grigoleit, MD, Jurgen Kuball, MDPhD, Ryan P Flynn, PhD, Gabriele Ihorst, PhD, Jing Du, Bruce R. Blazar, MD, Renate Arnold, MD, Nicolaus Kröger, MD, Joerg Halter, MD, Gerard Socie, Dietrich Beelen, MD, Christian Peschel, MD, Andreas Neubauer, MD, Juergen Finke, MD, Justus Duyster, MD PhD, Nikolas von Bubnoff, MD

Blood (2015) 126 (23): 858.

https://doi.org/10.1182/blood.V126.23.858.858

Published: 2015

NARROW

The IMiD-Target Cereblon Determines Transmembrane Protein Quality Control Promoting Tumor Metabolism

The Fanconi Anemia-Associated Protein NIPA Is Essential for the Nuclear Abundance of FANCD2

MOR202 with Low-Dose Dexamethasone (Dex) or Pomalidomide/Dex or Lenalidomide/Dex in Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis of a Phase I/IIa, Multicenter, Dose-Escalation Study

Azacitidine Directly Acts on the Mesenchymal Stromal Cell Compartment in Myelodysplastic Syndromes to Alter Niche Function and Suppress Malignant Hematopoeitic Stem/Progenitor Cells

Tumor-Intrinsic RIG-I Signaling Promotes Anti-CTLA-4 Checkpoint Inhibitor-Mediated Anticancer Immunity

Combination of 5-Azacytidine and ABT-199 Has a Synergistic Apoptotic Effect in High-Risk MDS/sAML after HMA Failure

Peptide-Receptor Radiotherapy with CXCR4-Targeting Pentixather Reduces Leukemia Burden in Acute Leukemia PDX and Patients

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Evasion of Necroptosis and Inflammasome Activation Promotes Myeloid Leukemogenesis

A Phase I/IIa Study of the CD38 Antibody MOR202 Alone and in Combination with Pomalidomide or Lenalidomide in Patients with Relapsed or Refractory Multiple Myeloma

Long-Term Follow-up of Patients with Corticosteroid-Refractory Graft-Versus-Host Disease Treated with Ruxolitinib

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma- Retrospective Analysis of 2 Randomized Trials of the German Low Grade Lymphoma Study Group ( GLSG )

Integration of innate into adaptive immune responses in ZAP-70–positive chronic lymphocytic leukemia

Identification of CXCR4 Expression By Targeted PET/MR Imaging in Patients with Acute Myeloid Leukemia (AML)

NIPA As a Novel Regulator of Aging and Stress Response of the Primitive HSC Pool

Significance of the IL-3 Receptor Beta Chain (IL-3Rbc) for FLT3-ITD Dependent Oncogeneic Signaling in AML

Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group

The RIG-I Agonist 3pRNA Synergizes with Checkpoint Blockade in Cancer Immunotherapy

Azacitidine in Combination with the Selective FLT3 Kinase Inhibitor Crenolanib Effectively Disrupts Stromal Protection of CD34+ Leukemia-Initiating Cells (LIC) in FLT3-ITD+ Acute Myeloid Leukemia (AML)

Treatment of Corticosteroid-Refractory Graft-Versus-Host Disease with Ruxolitinib in 95 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only